Out of 6 tumors of mice treated with the CXCR4 antagonist AMD3100, 2 showed focal intra- or peritumoral vessels while there was no tumor with distributed intratumoral vessels as seen in control mice (Fig. 8D-E). This evidence concerns the gene CXCR4 and neoplasm.